Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP453192.RA_nXZ433f0i8HTQ2ey8S6Qxx08we2qQvSLszi7ys5z_k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP453192.RA_nXZ433f0i8HTQ2ey8S6Qxx08we2qQvSLszi7ys5z_k130_assertion type Assertion NP453192.RA_nXZ433f0i8HTQ2ey8S6Qxx08we2qQvSLszi7ys5z_k130_head.
- NP453192.RA_nXZ433f0i8HTQ2ey8S6Qxx08we2qQvSLszi7ys5z_k130_assertion description "[We conducted a multicenter phase II trial of imatinib in metastatic mucosal, acral, or chronically sun-damaged (CSD) melanoma with KIT amplifications and/or mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP453192.RA_nXZ433f0i8HTQ2ey8S6Qxx08we2qQvSLszi7ys5z_k130_provenance.
- NP453192.RA_nXZ433f0i8HTQ2ey8S6Qxx08we2qQvSLszi7ys5z_k130_assertion evidence source_evidence_literature NP453192.RA_nXZ433f0i8HTQ2ey8S6Qxx08we2qQvSLszi7ys5z_k130_provenance.
- NP453192.RA_nXZ433f0i8HTQ2ey8S6Qxx08we2qQvSLszi7ys5z_k130_assertion SIO_000772 23775962 NP453192.RA_nXZ433f0i8HTQ2ey8S6Qxx08we2qQvSLszi7ys5z_k130_provenance.
- NP453192.RA_nXZ433f0i8HTQ2ey8S6Qxx08we2qQvSLszi7ys5z_k130_assertion wasDerivedFrom befree-20140225 NP453192.RA_nXZ433f0i8HTQ2ey8S6Qxx08we2qQvSLszi7ys5z_k130_provenance.
- NP453192.RA_nXZ433f0i8HTQ2ey8S6Qxx08we2qQvSLszi7ys5z_k130_assertion wasGeneratedBy ECO_0000203 NP453192.RA_nXZ433f0i8HTQ2ey8S6Qxx08we2qQvSLszi7ys5z_k130_provenance.